{"id":"NCT03397121","sponsor":"The Medicines Company","briefTitle":"Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)","officialTitle":"Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-11-28","primaryCompletion":"2019-08-27","completion":"2019-09-17","firstPosted":"2018-01-11","resultsPosted":"2020-10-28","lastUpdate":"2020-10-28"},"enrollment":482,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Heterozygous Familial Hypercholesterolemia","Elevated Cholesterol"],"interventions":[{"type":"DRUG","name":"Inclisiran","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":["Saline Solution"]}],"arms":[{"label":"Inclisiran","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase III, placebo-controlled, double-blind, randomized study in participants with HeFH and elevated LDL-C to evaluate the efficacy, safety, and tolerability of subcutaneous (SC) injection(s) of inclisiran. The study will be multicenter and international.","primaryOutcome":{"measure":"Percent Change in LDL-C From Baseline To Day 510","timeFrame":"Baseline, Day 510","effectByArm":[{"arm":"Inclisiran","deltaMin":-41.15,"sd":null},{"arm":"Placebo","deltaMin":8.37,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":45,"countries":["United States","Canada","Czechia","Denmark","Netherlands","South Africa","Spain","Sweden"]},"refs":{"pmids":["38063346","32197277"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":241},"commonTop":["Nasopharyngitis","Influenza","Upper respiratory tract infection","Back pain","Injection site reaction"]}}